IP Verse

Array Biopharma, Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of Array Biopharma, Inc. opposed by its competitors

Patent:
EP3400943
Grant Date:
Dec 2, 2020
Title:
Compounds For Use In The Treatment Of Erbb2+ Brain Cancer
Oppositions:
2
Patent:
EP3000810
Grant Date:
Jul 19, 2017
Title:
N3 Alkylated Benzimidazole Derivative As Mek Inhibitor
Oppositions:
1

Competitors of Array Biopharma, Inc.

GENERICS [UK] LIMITED (TRADING AS MYLAN)

SANDOZ AG

TEVA PHARMACEUTICAL INDUSTRIES LTD

Want to track Array Biopharma, Inc.?

Feel free to send us a message here and we will get back to you